• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年肺癌患者术后静脉血栓栓塞风险预测模型的开发与验证

Development and validation of a risk prediction model for venous thromboembolism after surgery in elderly patients with lung cancer.

作者信息

Lin Qing, Wang Shi, Zhang Xiangmei, Luo Jie, Chen Lijun, Xu Bingrui, Wang Shuqian

机构信息

The First Department of Thoracic Surgery, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, 361001, Fujian, China.

Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Xiamen University,School of Medicine, Xiamen University, Xiamen, 361001, Fujian, China.

出版信息

BMC Surg. 2025 Aug 9;25(1):357. doi: 10.1186/s12893-025-03080-8.

DOI:10.1186/s12893-025-03080-8
PMID:40783702
Abstract

OBJECTIVE

To develop and validate a risk prediction model for postoperative venous thromboembolism (VTE) in elderly patients (≥ 60 years old) with lung cancer using internal and external datasets, providing a reference for clinical prevention and management.

METHODS

A retrospective analysis was conducted on 320 elderly lung cancer patients who underwent surgery at our hospital between January 2023 and May 2024. Patients were categorized into a VTE group (55 cases) and a non-VTE group (265 cases) based on the occurrence of VTE within six months postoperatively. An additional 60 elderly lung cancer patients who underwent surgery between June and November 2024 were selected for external validation. General clinical characteristics were compared between the two groups, and risk factors for postoperative VTE were analyzed to construct and validate the predictive model.

RESULTS

The incidence of postoperative VTE was 17.19% (55/320). Compared with the non-VTE group, the VTE group had a significantly higher proportion of patients with a history of smoking, alcohol consumption, hypertension, extremely high-risk Caprini scores, surgical duration ≥ 120 min, open surgery, clinical stage III-IV disease, preoperative chemotherapy, positive D-dimer (D-D) >3.64 mg/L, and elevated C-reactive protein (CRP) levels (P < 0.05). Multivariate analysis identified extremely high-risk Caprini scores, surgical duration ≥ 120 min, open surgery, clinical stage III-IV disease, preoperative chemotherapy, positive D-D>3.64 mg/L, and elevated CRP levels as independent risk factors for postoperative VTE (P < 0.05). Receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA) demonstrated that the model had excellent discrimination, accuracy, and predictive performance.

CONCLUSION

The incidence of postoperative VTE in elderly lung cancer patients is relatively high. Key risk factors include an extremely high-risk Caprini score, surgical duration ≥ 120 min, open surgery, clinical stage III-IV disease, preoperative chemotherapy, positive D-D>3.64 mg/L, and elevated CRP levels. The nomogram-based risk prediction model developed in this study exhibits high discrimination and accuracy, with good predictive ability and clinical utility, providing a basis for targeted prevention and management strategies.

摘要

目的

利用内部和外部数据集开发并验证老年(≥60岁)肺癌患者术后静脉血栓栓塞症(VTE)的风险预测模型,为临床预防和管理提供参考。

方法

对2023年1月至2024年5月在我院接受手术的320例老年肺癌患者进行回顾性分析。根据术后6个月内VTE的发生情况,将患者分为VTE组(55例)和非VTE组(265例)。另外选取2024年6月至11月接受手术的60例老年肺癌患者进行外部验证。比较两组患者的一般临床特征,分析术后VTE的危险因素,构建并验证预测模型。

结果

术后VTE发生率为17.19%(55/320)。与非VTE组相比,VTE组患者中有吸烟史、饮酒史、高血压、Caprini评分极高危、手术时长≥120分钟、开放手术、临床分期为III-IV期疾病、术前化疗、D-二聚体(D-D)阳性>3.64mg/L以及C反应蛋白(CRP)水平升高的比例显著更高(P<0.05)。多因素分析确定Caprini评分极高危、手术时长≥120分钟、开放手术、临床分期为III-IV期疾病、术前化疗、D-D阳性>3.64mg/L以及CRP水平升高是术后VTE的独立危险因素(P<0.05)。受试者工作特征(ROC)曲线、校准曲线和决策曲线分析(DCA)表明该模型具有出色的区分度、准确性和预测性能。

结论

老年肺癌患者术后VTE发生率较高。关键危险因素包括Caprini评分极高危、手术时长≥120分钟、开放手术、临床分期为III-IV期疾病、术前化疗、D-D阳性>3.64mg/L以及CRP水平升高。本研究开发的基于列线图的风险预测模型具有较高的区分度和准确性,具有良好的预测能力和临床实用性,为针对性的预防和管理策略提供了依据。

相似文献

1
Development and validation of a risk prediction model for venous thromboembolism after surgery in elderly patients with lung cancer.老年肺癌患者术后静脉血栓栓塞风险预测模型的开发与验证
BMC Surg. 2025 Aug 9;25(1):357. doi: 10.1186/s12893-025-03080-8.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.首次特发性静脉血栓栓塞症治疗后静脉血栓栓塞症复发风险的预测:系统评价、预后模型与临床决策规则以及经济学评估
Health Technol Assess. 2016 Feb;20(12):i-xxxiii, 1-190. doi: 10.3310/hta20120.
4
High Risk of Venous Thromboembolism With Aspirin Prophylaxis After THA for High-riding Developmental Dysplasia of the Hip: A Retrospective, Comparative Study.髋关节高位发育性髋关节发育不良全髋关节置换术后阿司匹林预防静脉血栓栓塞的高风险:一项回顾性比较研究。
Clin Orthop Relat Res. 2025 Jun 9. doi: 10.1097/CORR.0000000000003482.
5
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.缺失数据的存在是否会影响 SORG 机器学习算法在脊柱转移瘤患者中的性能?开发一种互联网应用算法。
Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12.
6
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
7
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
8
A systematic review of risk prediction model of venous thromboembolism for patients with lung cancer.系统评价肺癌患者静脉血栓栓塞症的风险预测模型。
Thorac Cancer. 2024 Feb;15(4):277-285. doi: 10.1111/1759-7714.15219. Epub 2024 Jan 17.
9
Venous Thromboembolism Risk Assessment in Inpatient and Ambulatory Otolaryngology Surgical Patients.住院及门诊耳鼻喉科手术患者的静脉血栓栓塞风险评估
Laryngoscope. 2025 Apr;135(4):1359-1366. doi: 10.1002/lary.31856. Epub 2024 Oct 29.
10
Development and validation of a nomogram for predicting postoperative venous thromboembolism risk in patients with hepatocellular carcinoma.预测肝细胞癌患者术后静脉血栓栓塞风险的列线图的开发与验证
World J Gastrointest Oncol. 2025 Jun 15;17(6):105790. doi: 10.4251/wjgo.v17.i6.105790.

本文引用的文献

1
A Thoracic Surgery-Specific Risk Assessment Model to Prevent Perioperative Venous Thromboembolism.一种预防围手术期静脉血栓栓塞的胸外科特异性风险评估模型。
Ann Thorac Surg Short Rep. 2022 Oct 29;1(1):194-198. doi: 10.1016/j.atssr.2022.10.014. eCollection 2023 Mar.
2
Venous thromboembolism in patients undergoing surgery for lung cancer: a post hoc analysis of the Cancer-VTE Registry.肺癌手术患者的静脉血栓栓塞症:癌症-静脉血栓栓塞症登记处的事后分析。
Jpn J Clin Oncol. 2024 Nov 2;54(11):1219-1223. doi: 10.1093/jjco/hyae090.
3
Association between epidermal growth factor receptor-tyrosine kinase inhibitors and venous thromboembolism among older patients with advanced non-small cell lung cancer.
老年晚期非小细胞肺癌患者中表皮生长因子受体-酪氨酸激酶抑制剂与静脉血栓栓塞之间的关联
Cancer. 2024 Oct 15;130(20):3412-3425. doi: 10.1002/cncr.35424. Epub 2024 Jun 7.
4
Venous Thromboembolism as Postoperative Complication After Lung Cancer Operations.
Ann Thorac Surg. 2024 May;117(5):1005-1006. doi: 10.1016/j.athoracsur.2024.03.005. Epub 2024 Mar 15.
5
Predictors of Venous Thromboembolism After Lung Cancer Resection.肺癌切除术后静脉血栓栓塞症的预测因素。
Ann Thorac Surg. 2024 May;117(5):998-1005. doi: 10.1016/j.athoracsur.2024.01.005. Epub 2024 Jan 29.
6
A systematic review of risk prediction model of venous thromboembolism for patients with lung cancer.系统评价肺癌患者静脉血栓栓塞症的风险预测模型。
Thorac Cancer. 2024 Feb;15(4):277-285. doi: 10.1111/1759-7714.15219. Epub 2024 Jan 17.
7
[Perioperative Management of Deep Vein Thrombosis and Treatment of Pulmonary Embolism].
Kyobu Geka. 2023 Sep;76(10):849-854.
8
Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model.肺癌合并静脉血栓栓塞症患者的早期识别:风险预测模型的建立与验证
Thromb J. 2023 Sep 14;21(1):95. doi: 10.1186/s12959-023-00544-w.
9
[Analysis of the Incidence of Lower Limb Deep Venous Thrombosis 
and Its Related Risk Factors in the Postoperative Patients with Lung Cancer].[肺癌术后患者下肢深静脉血栓形成的发生率及其相关危险因素分析]
Zhongguo Fei Ai Za Zhi. 2023 May 20;26(5):386-391. doi: 10.3779/j.issn.1009-3419.2023.102.16.
10
Nomogram prediction for the risk of venous thromboembolism in patients with lung cancer.肺癌患者静脉血栓栓塞风险的列线图预测
Cancer Cell Int. 2023 Mar 5;23(1):40. doi: 10.1186/s12935-023-02882-1.